The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,408.50
Bid: 1,402.50
Ask: 1,404.00
Change: -5.00 (-0.35%)
Spread: 1.50 (0.107%)
Open: 1,412.50
High: 1,424.50
Low: 1,393.00
Prev. Close: 1,413.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

13 Jan 2022 07:04

RNS Number : 2776Y
Persimmon PLC
12 January 2022
 

13 January 2022

Persimmon Plc

("Persimmon" or "the Group")

 

Appointment of Chief Financial Officer

 

The Board of Persimmon Plc is pleased to announce the appointment of Jason Windsor as Chief Financial Officer. Jason is expected to join in the summer and will become an Executive Director on the Board at that time. He will succeed Mike Killoran, who announced in July 2021 that he would be retiring in mid-January 2022 after more than 25 years with the Group.

 

Jason is an experienced finance executive who has established a strong track record in a variety of senior financial roles over the last 26 years. He has been Group Chief Financial Officer of Aviva PLC since 2019, having previously been Chief Financial Officer of both its UK Insurance and UK Life businesses, after originally joining the business in 2010. Prior to that he spent 15 years at Morgan Stanley, latterly as a Managing Director within its Investment Banking Division.

 

Roger Devlin, Persimmon's Chairman, said: "Jason is a well-respected and proven FTSE 100 CFO and we are delighted to have recruited someone of his calibre and experience as Chief Financial Officer to complement our strong management team. In his current role Jason has demonstrated an ability to deliver sustained financial and strategic progress while working in a large consumer-facing business. These skills will be highly relevant and transferable to Persimmon as we continue our drive to become the leading builder of good value, quality family homes in the UK. We look forward to welcoming him to the Group in the summer.

 

"I would also like to thank Mike Killoran once again for his significant contribution to the success of Persimmon over many years. Everyone at Persimmon wishes Mike well in his retirement."

 

Jason Windsor said: "I'm delighted to be joining the Group and excited by the opportunities ahead. Persimmon has a leading position in a critical sector of the UK economy and I'm looking forward to working with the team as they continue their journey to becoming Britain's best housebuilder, whilst maintaining industry-leading financial returns."

 

Mike Killoran will leave the Group as planned on 14 January 2022. With Jason expected to join in the summer, Dean Finch, Group Chief Executive, will assume interim responsibility for the finance function. Dean will be supported by Mike Smith, Group Financial Controller - Reporting, and Jim Wilkinson, Group Financial Controller - Operations.

 

Remuneration

 

Jason Windsor

 

All remuneration arrangements for Jason are consistent with the terms of the Directors' Remuneration Policy approved by shareholders at the AGM in April 2020. As Chief Financial Officer, Jason will receive an annual base salary of £675,000, which is the same as his salary at Aviva, and a pension allowance of 9% of salary in line with the contribution available for Persimmon's salaried employees. For 2022 Jason will also be able to participate in the Company's existing annual bonus plan up to a maximum of 175% of salary (with 50% of any bonus earned being deferred into Persimmon shares for three years), and the Performance Share Plan up to 200% of salary (based on performance over three years and subject to a further two year holding period). Jason's remuneration is at a similar level to his existing package at Aviva. As set out in the remuneration policy for the Executive Directors, a proportion of Jason's remuneration will be based on non-financial metrics including customer care and quality.

 

Jason will also receive awards to compensate for remuneration he is forfeiting on leaving his previous employer. These will remain subject to performance conditions where appropriate and reflect the value of the forfeited awards. The vesting timeline of the replacement awards will be the same as those which apply to the forfeited awards. Details will be disclosed in Persimmon's Directors' Remuneration Report for the year ending 31 December 2021.

 

Mike Killoran

 

Mike Killoran will receive his salary and benefits up until the date of his retirement on 14 January 2022. The Remuneration Committee has determined that Mike will be treated as a Good Leaver and he will therefore receive any bonus earned for the year ended 31 December 2021 and outstanding Performance Share Plan awards on a time pro-rated basis and subject to the performance conditions, in recognition of his significant contribution to the success of the Group over many years. Vesting will occur on the normal dates. Details of the remuneration arrangements relating to Mike Killoran can be found on the Group website at: www.persimmonhomes.com/corporate/investors/corporate-governance/board-of-directors.

 

Jason Windsor is also a director of General Accident PLC, a subsidiary of Aviva PLC. There are no further disclosures required in respect of Listing Rule 9.6.13.

 

For further information, please contact:

 

Citigate Dewe Rogerson

 

Kevin Smith / Jos Bieneman

 

Tel: +44 (0)20 7638 9571

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFIFAEEESELF
Date   Source Headline
28th Apr 20217:00 amRNSTrading Update
1st Apr 20213:52 pmRNSTotal Voting Rights
26th Mar 20211:20 pmRNSAnnual Report 2020 and Notice of AGM 2021
23rd Mar 20213:27 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:09 amRNSDirector Declaration
22nd Mar 202111:01 amRNSDirector/PDMR Shareholding
8th Mar 20211:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSFinal Results
1st Mar 20213:52 pmRNSTotal Voting Rights
10th Feb 20217:00 amRNSPersimmon Acts to Address Legacy Cladding Issues
1st Feb 20212:19 pmRNSTotal Voting Rights
13th Jan 20217:00 amRNSTrading Statement
4th Jan 20213:10 pmRNSTotal Voting Rights
17th Dec 20201:12 pmRNSAppointment of Independent Non-Executive Director
15th Dec 20207:00 amRNSComposition of Remuneration Committee
8th Dec 20203:50 pmRNSDirector/PDMR Shareholding
1st Dec 20203:22 pmRNSBlock listing Interim Review
1st Dec 20203:01 pmRNSTotal Voting Rights
25th Nov 202011:50 amRNSAdditional Listing
10th Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20203:11 pmRNSTotal Voting Rights
27th Oct 20203:37 pmRNSAdditional Listing
16th Oct 202012:46 pmRNSGrant of SAYE Option
29th Sep 202012:27 pmRNSDirector/PDMR Shareholding
8th Sep 202010:25 amRNSNew Chief Executive Officer Start Date
1st Sep 20202:00 pmRNSTotal Voting Rights
28th Aug 20202:02 pmRNSDirector/PDMR Shareholding
26th Aug 20207:44 amRNSPersimmon Plc (PSN) - Additional Listing
19th Aug 20207:02 amRNSUpdate on Chief Executive Officer Appointment
18th Aug 20207:00 amRNSHalf Year Results
20th Jul 20201:49 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSTrading Update
1st Jul 202012:42 pmRNSTotal Voting Rights
29th Jun 20204:58 pmRNSAppointment of CEO
24th Jun 20207:00 amRNSAppointment of new Chief Executive Officer
8th Jun 20204:17 pmRNSDirectorate Change
5th Jun 202010:00 amRNSDirector/PDMR Shareholding
1st Jun 20202:05 pmRNSBlock listing Interim Review
1st Jun 20201:13 pmRNSTotal Voting Rights
26th May 20202:28 pmRNSDirector/PDMR Shareholding
20th May 20208:40 amRNSDirector Declaration
14th May 20207:00 amRNSCOVID-19 Update
1st May 20201:56 pmRNSTotal Voting Rights
29th Apr 20203:34 pmRNSResult of AGM
29th Apr 20207:01 amRNSBoard Change
29th Apr 20207:00 amRNSTrading Update
27th Apr 20204:32 pmRNSDisclosure of rights attached to equity shares
24th Apr 20207:00 amRNSCOVID-19 Update
3rd Apr 20209:16 amRNSDirector Declaration
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.